Literature DB >> 17884109

Nitrous oxide (N2O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats.

Baptiste Bessière1, Philippe Richebé, Emilie Laboureyras, Jean-Paul Laulin, Angelo Contarino, Guy Simonnet.   

Abstract

Improving rehabilitation after a severe tissue injury does not only require a reduction in pain, but also requires alleviation of negative affects, particularly anxiety. Although opioids remain unsurpassed analgesics to relieve moderate to severe pain, it has been shown that they also induce latent pain sensitization leading to long-lasting hyperalgesia via N-methyl-D-aspartate-(NMDA)-dependent pronociceptive systems. The present study evaluated the ability of nitrous oxide (N2O), a gas with NMDA antagonist properties, to prevent latent pain sensitization and long-term anxiety-like behavior (ALB) in rats with pain and opioid experiences. On D0, the pro-inflammatory drug carrageenan was injected in one hind paw of rats treated with fentanyl (4x100 microg/kg subcutaneously). Nociceptive threshold was evaluated with the paw pressure vocalization test. Rats were re-exposed to carrageenan or exposed to repeated non-nociceptive environmental stress (NNES) 2-3 weeks later. Rats were also challenged in the elevated plus-maze 2 weeks after fentanyl administration for evaluating ALB. The preventive effects of a single 4 h 50/50% N2O-O2 exposure performed on D0 was evaluated. Fifty percent N2O strongly reduced hyperalgesia induced by a first inflammation and its enhancement by fentanyl, and prevented exaggerated hyperalgesia induced by second inflammatory pain or NNES. Moreover, we provide first evidence that a high fentanyl dose induces long-term ALB 2 weeks after its administration. When associated with fentanyl, 50% N2O prevented such long-term ALB. These results suggest that a single exposure to N2O could improve post-injury pain management and facilitate rehabilitation especially when potent analgesics as opioids have to be used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884109     DOI: 10.1016/j.neuropharm.2007.08.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Latent sensitization: a model for stress-sensitive chronic pain.

Authors:  Juan Carlos Marvizon; Wendy Walwyn; Ani Minasyan; Wenling Chen; Bradley K Taylor
Journal:  Curr Protoc Neurosci       Date:  2015-04-01

2.  Robust thermoregulatory overcompensation, rather than tolerance, develops with serial administrations of 70% nitrous oxide to rats.

Authors:  Karl J Kaiyala; Ben Chan; Douglas S Ramsay
Journal:  J Therm Biol       Date:  2012-01-01       Impact factor: 2.902

3.  Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.

Authors:  Dioneia Araldi; Luiz F Ferrari; Jon D Levine
Journal:  Pain       Date:  2017-07       Impact factor: 7.926

4.  Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity.

Authors:  Wendy M Walwyn; Wenling Chen; Hyeyoung Kim; Ani Minasyan; Helena S Ennes; James A McRoberts; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2016-01-06       Impact factor: 6.167

5.  Nitrous oxide effect on relieving anxiety and pain in parturients under spinal anesthesia for caesarean section.

Authors:  Nahid Manouchehrian; Mohammad Hossein Bakhshaei
Journal:  Anesth Pain Med       Date:  2014-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.